cipla News

Cipla infringing Roche’s patent in lung cancer drug, says Delhi HC

Delhi HC refused to issue any injunction against Cipla restraining it from manufacturing the medicine, after observing that the life of the patent granted to Roche was ending in March 2016.

Cipla enhances US push with 2 buys for $550 mn

Cipla will as a result of these acquisitions gain multiple products in the areas of anti-infectives, diabetes and central nervous system disorders.


Cipla’s gain in German firm’s drug patent loss

Cipla had challenged the patent, arguing that Tiotropium bromide monohydrate, sold under the brand name Spiriva.

Cipla challenges HC order against manufacturing generic drug

Cipla had last year started manufacturing and selling a generic drug using the Indacaterol maleate salt.

HC bars Cipla from selling drug containing Indacaterol

The firm has been selling the drug in India under the trademark ‘Onbrez’ through Lupin since 2010.

Judgment reserved on Novartis-Cipla patent dispute

Novartis has also sought damages and payment for infringing the patented pharmaceutical product.


Innovation that includes

The pharmaceutical industry needs to shed its archaic blockbuster model.

India Inc has time till Oct 1 to bring women on board

A look at the 30 bluechip companies that form the benchmark Sensex at the Bombay Stock Exchange reveals that over one third or 11 companies including Reliance Industries, TCS, ONGC and L&T do not have a woman director.

BSE Sensex drops 42 pts to over week's low ahead of RBI policy review meet

The BSE Sensex fell 42 points amid profit booking today.

BSE Sensex continues retreat from 3-year closing high,Gail India,Cipla shares top gainers

BSE Sensex falls 0.47 pct,NSE Nifty ends 0.39 pct lower,FIIs remain net buyers of Indian shares.